Transmission pattern of drug-resistant tuberculosis and its implication for tuberculosis control in eastern rural China

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Hu, Yi ^a   Mathema, Barun ^b   Jiang, Weili ^a   Kreiswirth, Barry ^b   Wang, Weibing ^a   Xu, Biao ^a  

^a FUDAN UNIVERSITY   (China)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CHINA; CONTROLLED STUDY; DRUG RESISTANT TUBERCULOSIS; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPIC VARIATION; PRIMARY HEALTH CARE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RURAL AREA; SHORT COURSE THERAPY; SPUTUM SMEAR; TUBERCULOSIS CONTROL; AGED; DIRECTLY OBSERVED THERAPY; DISEASE TRANSMISSION; DRUG EFFECT; GENETICS; GENOTYPE; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; RURAL POPULATION;

MYCOBACTERIUM TUBERCULOSIS;

ADULT; AGED; ANTITUBERCULAR AGENTS; CHINA; DIRECTLY OBSERVED THERAPY; FEMALE; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RURAL POPULATION; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 79955935916     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019548     Document Type: Article

References (35)

1. Cohn DL, Bustreo F, Raviglione MC, (1997) Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin Infect Dis 24 (Suppl 1): S121-130.
2. Resch SC, Salomon JA, Murray M, Weinstein MC, (2006) Cost-effectiveness of treating multidrug-resistant tuberculosis. PLoS Med 3: e241.
3. Mohammadi A, Nassor ZS, Behlim T, Mohammadi E, Govindarajan R, et al. (2008) Epidemiological and cost analysis of multidrug-resistant tuberculosis in Oman. East Mediterr Health J 14: 1240-1245.
4. Pritchard AJ, Hayward AC, Monk PN, Neal KR, (2003) Risk factors for drug resistant tuberculosis in Leicestershire-poor adherence to treatment remains an important cause of resistance. Epidemiol Infect 130: 481-483.
5. Cohn ML, Davis CL, (1970) Infectivity and pathogenicity of drug-resistant strains of tubercle bacilli studied by aerogenic infection of guinea pigs. Am Rev Respir Dis 102: 97-100.
6. Agerton T, Valway S, Gore B, Pozsik C, Plikaytis B, et al. (1997) Transmission of a highly drug-resistant strain (strain W1) of Mycobacterium tuberculosis. Community outbreak and nosocomial transmission via a contaminated bronchoscope. JAMA 278: 1073-1077.
7. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, et al. (2006) Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368: 1575-1580.
8. Shenoi SV, Escombe AR, Friedland G, (2010) Transmission of drug-susceptible and drug-resistant tuberculosis and the critical importance of airborne infection control in the era of HIV infection and highly active antiretroviral therapy rollouts. Clin Infect Dis 50 (Suppl 3): S231-237.
9. Basu S, Andrews JR, Poolman EM, Gandhi NR, Shah NS, et al. (2007) Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet 370: 1500-1507.
10. Sun YJ, Lee AS, Wong SY, Heersma H, Kremer K, et al. (2007) Genotype and phenotype relationships and transmission analysis of drug-resistant tuberculosis in Singapore. Int J Tuberc Lung Dis 11: 436-442.
11. Quitugua TN, Seaworth BJ, Weis SE, Taylor JP, Gillette JS, et al. (2002) Transmission of drug-resistant tuberculosis in Texas and Mexico. J Clin Microbiol 40: 2716-2724.
12. Li X, Zhang Y, Shen X, Shen G, Gui X, et al. (2007) Transmission of drug-resistant tuberculosis among treated patients in Shanghai, China. J Infect Dis 195: 864-869.
13. Wang L, Liu J, Chin DP, (2007) Progress in tuberculosis control and the evolving public-health system in China. Lancet 369: 691-696.
14. Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, et al. (2009) Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 373: 1861-1873.
15. Hu Y, Mathema B, Wang W, Hoffner S, Kreiswirth B, et al. (2008) Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China. Microb Drug Resist 14: 227-232.
16. Hu Y, Hoffner S, Jiang W, Wang W, Xu B, (2010) Genetic characterisation of drug-resistant Mycobacterium tuberculosis in rural China: a population-based study. Int J Tuberc Lung Dis 14: 210-216.
17. Hu Y, Ma X, Graviss EA, Wang W, Jiang W, et al. (2011) A major subgroup of Beijing family Mycobacterium tuberculosis is associated with multidrug resistance and increased transmissibility. Epidemiol Infect 139: 130-138.
18. Hu Y, Hoffner S, Jiang W, Wang W, Xu B, (2010) Extensive transmission of isoniazid resistant M. tuberculosis and its association with increased multidrug-resistant TB in two rural counties of eastern China: a molecular epidemiological study. BMC Infect Dis 10: 43.
19. The WHO, (2008) The WHO/IUATLD Global Project on Anti-tuberculosis drug resistance surveillance. Anti-tuberculosis Drug Resistance in the World, 4th Global Report. Available: http://www.who.int/tb/publications/2008/drs_report4_26feb08.pdf. Accessed 2010 Jun 1.
20. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, et al. (1993) Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 31: 406-409.
21. Vitol I, Driscoll J, Kreiswirth B, Kurepina N, Bennett KP, (2006) Identifying Mycobacterium tuberculosis complex strain families using spoligotypes. Infect Genet Evol 6: 491-504.
22. Li GL, Zhao DF, Xie T, Ju HF, Mu C, et al. (2010) Molecular characterization of drug-resistant Beijing family isolates of Mycobacterium tuberculosis from Tianjin, China. Biomed Environ Sci 23: 188-193.
23. Drobniewski F, Balabanova Y, Ruddy M, Weldon L, Jeltkova K, et al. (2002) Rifampin- and multidrug-resistant tuberculosis in Russian civilians and prison inmates: dominance of the beijing strain family. Emerg Infect Dis 8: 1320-1326.
24. Park YK, Shin S, Ryu S, Cho SN, Koh WJ, et al. (2005) Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea. J Microbiol Methods 63: 165-172.
25. Phyu S, Stavrum R, Lwin T, Svendsen OS, Ti T, et al. (2009) Predominance of Mycobacterium tuberculosis EAI and Beijing lineages in Yangon, Myanmar. J Clin Microbiol 47: 335-344.
26. Ohata R, Tada A, (2004) [Beijing family and other genotypes of Mycobacterium tuberculosis isolates in Okayama district]. Kekkaku 79: 47-53.
27. Aristimuno L, Armengol R, Cebollada A, Espana M, Guilarte A, et al. (2006) Molecular characterisation of Mycobacterium tuberculosis isolates in the First National Survey of Anti-tuberculosis Drug Resistance from Venezuela. BMC Microbiol 6: 90.
28. Telles MA, Ferrazoli L, Waldman EA, Giampaglia CM, Martins MC, et al. (2005) A population-based study of drug resistance and transmission of tuberculosis in an urban community. Int J Tuberc Lung Dis 9: 970-976.
29. D'Souza D T, Mistry NF, Vira TS, Dholakia Y, Hoffner S, et al. (2009) High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India. BMC Public Health 9: 211.
30. Kelly PM, Lumb R, Pinto A, da Costa G, Sarmento J, et al. (2005) Analysis of Mycobacterium tuberculosis isolates from treatment failure patients living in East Timor. Int J Tuberc Lung Dis 9: 81-86.
31. Varela G, Gonzalez S, Gadea P, Coitinho C, Mota I, et al. (2008) Prevalence and dissemination of the Ser315Thr substitution within the KatG enzyme in isoniazid-resistant strains of Mycobacterium tuberculosis isolated in Uruguay. J Med Microbiol 57: 1518-1522.
32. Ano H, Matsumoto T, Suetake T, Nagai T, Tamura Y, et al. (2008) Relationship between the isoniazid-resistant mutation katGS315T and the prevalence of MDR-/XDR-TB in Osaka, Japan. Int J Tuberc Lung Dis 12: 1300-1305.
33. Mokrousov I, Narvskaya O, Vyazovaya A, Millet J, Otten T, et al. (2008) Mycobacterium tuberculosis Beijing genotype in Russia: in search of informative variable-number tandem-repeat loci. J Clin Microbiol 46: 3576-3584.
34. Valcheva V, Mokrousov I, Narvskaya O, Rastogi N, Markova N, (2008) Utility of new 24-locus variable-number tandem-repeat typing for discriminating Mycobacterium tuberculosis clinical isolates collected in Bulgaria. J Clin Microbiol 46: 3005-3011.
35. Abadia E, Sequera M, Ortega D, Mendez MV, Escalona A, et al. (2009) Mycobacterium tuberculosis ecology in Venezuela: epidemiologic correlates of common spoligotypes and a large clonal cluster defined by MIRU-VNTR-24. BMC Infect Dis 9: 122.